Header Logo

Connection

Ali Keshavarzian to Inflammatory Bowel Diseases

Back to Details
This is a "connection" page, showing publications Ali Keshavarzian has written about Inflammatory Bowel Diseases.
Ali Keshavarzian
Connection Strength
8.585
Inflammatory Bowel Diseases
  1. Impact of Chronotherapy on 6-Mercaptopurine Metabolites in Inflammatory Bowel Disease: A Pilot Crossover Trial. Clin Transl Gastroenterol. 2023 02 01; 14(2):e00549.
    View in: PubMed
    Score: 0.788
  2. Complementary and Alternative Treatments Are Needed to Enhance the Care of the Inflammatory Bowel Disease Patient. Gastroenterol Clin North Am. 2017 12; 46(4):xiii-xiv.
    View in: PubMed
    Score: 0.545
  3. Getting personal: a review of sexual functioning, body image, and their impact on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015 Apr; 21(4):923-38.
    View in: PubMed
    Score: 0.458
  4. The relationship between coping, health competence and patient participation among patients with inactive inflammatory bowel disease. J Crohns Colitis. 2014 05; 8(5):401-8.
    View in: PubMed
    Score: 0.416
  5. Diagnostic medical radiation in inflammatory bowel disease: how to limit risk and maximize benefit. Inflamm Bowel Dis. 2013 Oct; 19(11):2501-8.
    View in: PubMed
    Score: 0.412
  6. Lymphogranuloma venereum proctosigmoiditis is a mimicker of inflammatory bowel disease. World J Gastroenterol. 2012 Jul 07; 18(25):3317-21.
    View in: PubMed
    Score: 0.379
  7. Addressing the mind, body, and spirit in a gastrointestinal practice for inflammatory bowel disease patients. Clin Gastroenterol Hepatol. 2012 Mar; 10(3):244-6.
    View in: PubMed
    Score: 0.364
  8. New molecular insights into inflammatory bowel disease-induced diarrhea. Expert Rev Gastroenterol Hepatol. 2011 Oct; 5(5):615-25.
    View in: PubMed
    Score: 0.359
  9. Sleep disturbances and inflammatory bowel disease: a potential trigger for disease flare? Expert Rev Clin Immunol. 2011 Jan; 7(1):29-36.
    View in: PubMed
    Score: 0.341
  10. Endogenous melatonin profiles in asymptomatic inflammatory bowel disease. Scand J Gastroenterol. 2010 Jun; 45(6):759-61.
    View in: PubMed
    Score: 0.327
  11. Pattern of alcohol consumption and its effect on gastrointestinal symptoms in inflammatory bowel disease. Alcohol. 2010 May; 44(3):223-8.
    View in: PubMed
    Score: 0.325
  12. The role of matrix metalloproteinases in intestinal epithelial wound healing during normal and inflammatory states. J Surg Res. 2011 Jun 15; 168(2):315-24.
    View in: PubMed
    Score: 0.323
  13. Current therapeutic approaches in inflammatory bowel disease. Curr Pharm Des. 2010; 16(33):3668-83.
    View in: PubMed
    Score: 0.318
  14. Impact of sleep disturbances in inflammatory bowel disease. J Gastroenterol Hepatol. 2007 Nov; 22(11):1748-53.
    View in: PubMed
    Score: 0.274
  15. Feasibility and acceptability of gut-directed hypnosis on inflammatory bowel disease: a brief communication. Int J Clin Exp Hypn. 2007 Oct; 55(4):457-66.
    View in: PubMed
    Score: 0.272
  16. Phosphodiesterase 4 inhibitors and inflammatory bowel disease: emerging therapies in inflammatory bowel disease. Expert Opin Investig Drugs. 2007 Sep; 16(9):1489-506.
    View in: PubMed
    Score: 0.271
  17. Mucosal mast cells are pivotal elements in inflammatory bowel disease that connect the dots: stress, intestinal hyperpermeability and inflammation. World J Gastroenterol. 2007 Jun 14; 13(22):3027-30.
    View in: PubMed
    Score: 0.266
  18. Biological variability and targeted delivery of therapeutics for inflammatory bowel diseases: an in silico approach. Inflamm Allergy Drug Targets. 2007 Mar; 6(1):47-55.
    View in: PubMed
    Score: 0.261
  19. An initial report of sleep disturbance in inactive inflammatory bowel disease. J Clin Sleep Med. 2006 Oct 15; 2(4):409-16.
    View in: PubMed
    Score: 0.255
  20. Direct Action of Non-Digestible Oligosaccharides against a Leaky Gut. Nutrients. 2022 Nov 07; 14(21).
    View in: PubMed
    Score: 0.194
  21. New developments in the treatment of inflammatory bowel disease. Expert Opin Investig Drugs. 2002 Mar; 11(3):365-85.
    View in: PubMed
    Score: 0.185
  22. The risk of revision following total hip arthroplasty in patients with inflammatory bowel disease, a registry based study. PLoS One. 2021; 16(11):e0257310.
    View in: PubMed
    Score: 0.181
  23. Chronotype, social jet lag, sleep debt and food timing in inflammatory bowel disease. Sleep Med. 2018 12; 52:188-195.
    View in: PubMed
    Score: 0.145
  24. Intestinal microbiota: a regulator of intestinal inflammation and cardiac ischemia? Curr Drug Targets. 2015; 16(3):199-208.
    View in: PubMed
    Score: 0.112
  25. Classification methods for the analysis of LH-PCR data associated with inflammatory bowel disease patients. Int J Bioinform Res Appl. 2015; 11(2):111-29.
    View in: PubMed
    Score: 0.112
  26. Hepatitis B vaccination in patients with inflammatory bowel disease. World J Gastroenterol. 2014 Nov 07; 20(41):15358-66.
    View in: PubMed
    Score: 0.111
  27. Starch-entrapped microspheres show a beneficial fermentation profile and decrease in potentially harmful bacteria during in vitro fermentation in faecal microbiota obtained from patients with inflammatory bowel disease. Br J Nutr. 2010 May; 103(10):1514-24.
    View in: PubMed
    Score: 0.079
  28. Reduced immunostaining for c-kit receptors in mucosal mast cells in inflammatory bowel disease. J Gastroenterol Hepatol. 2007 Dec; 22(12):2338-43.
    View in: PubMed
    Score: 0.067
  29. Influence of dietary fiber on inflammatory bowel disease and colon cancer: importance of fermentation pattern. Nutr Rev. 2007 Feb; 65(2):51-62.
    View in: PubMed
    Score: 0.065
  30. Regulation of oxidant-induced intestinal permeability by metalloprotease-dependent epidermal growth factor receptor signaling. J Pharmacol Exp Ther. 2007 Apr; 321(1):84-97.
    View in: PubMed
    Score: 0.065
  31. Use of herbal preparations in the treatment of oxidant-mediated inflammatory disorders. Complement Ther Med. 2007 Sep; 15(3):207-16.
    View in: PubMed
    Score: 0.063
  32. Heightened responses to stressors in patients with inflammatory bowel disease. Am J Gastroenterol. 2005 Aug; 100(8):1796-804.
    View in: PubMed
    Score: 0.059
  33. theta Isoform of protein kinase C alters barrier function in intestinal epithelium through modulation of distinct claudin isotypes: a novel mechanism for regulation of permeability. J Pharmacol Exp Ther. 2005 Jun; 313(3):962-82.
    View in: PubMed
    Score: 0.058
  34. PKC-zeta is required in EGF protection of microtubules and intestinal barrier integrity against oxidant injury. Am J Physiol Gastrointest Liver Physiol. 2002 May; 282(5):G794-808.
    View in: PubMed
    Score: 0.047
  35. Oxidant-induced intestinal barrier disruption and its prevention by growth factors in a human colonic cell line: role of the microtubule cytoskeleton. Free Radic Biol Med. 2000 Mar 01; 28(5):727-38.
    View in: PubMed
    Score: 0.040
  36. Reactive oxygen and nitrogen metabolites as mediators of secretory diarrhea. Gastroenterology. 1995 Dec; 109(6):2019-28.
    View in: PubMed
    Score: 0.030
  37. Quantitative assessment of the human gut microbiome using multitag pyrosequencing. Chem Biodivers. 2010 May; 7(5):1065-75.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.